On September 5, 2023, the pan-Canadian Pharmaceutical Alliance (pCPA) announced the appointment of Douglas Clark as its first CEO, effective September 11, 2023. Clark was Executive Director of the Patented Medicine Prices Review Board (PMPRB) for almost a decade before he resigned from that position earlier this year.... Read More
News & Events
05
Sep2023
03
Aug2023
PCPA Seeks Stakeholder Input On Its Proposed Process To Implement CADTH Time-Limited Recommendations
/ News, pCPA, What's New
The pan-Canadian Pharmaceutical Alliance (pCPA) introduced its proposed pCPA Temporary Access Process (pTAP) and invited stakeholders’ input on the process, its principles and conditions by August 18th, 2023.
The proposed pTAP and its associated principles are intended to inform pCPA negotiations and product listing agreements for ... Read More
11
Jul2023
On June 6, 2023, the Patented Medicine Prices Review Board (PMPRB) released its first NEWSletter of 2023, providing updates on recent activities among the Board and Board staff. Updates from the NEWSletter and PDCI’s insights on potential implications are summarized below. Despite recent quietness from PMPRB on its ... Read More
11
Jul2023
CADTH Announces Changes to Reimbursement Reviews Process & Fee Schedule Update
/ CADTH, News, What's New
On June 5, 2023, the Canadian Agency for Drugs and Technologies in Health (CADTH) announced a series of process improvements it plans to explore or add to its drug reimbursement review process. These changes - aimed at gaining efficiencies, reducing timelines and improving transparency – include:... Read More
11
Jul2023
On June 20, 2023, PMPRB published proposed amendments to the Interim Guidance relating to New Medicines. PMPRB has invited stakeholders to comment on the approach before August 21, 2023 (60-day consultation). After stakeholder consultation, a new set of guidelines is anticipated to be finalized in 2024.... Read More
02
May2023
Join us on May 31st @ 12 p.m. ET for our upcoming webinar entitled: Tips for Health Technology Assessment (HTA) Submissions: Plan your Trip, Pack your Bags and Leave on Time. Join PDCI HTA Experts Andrea Lau (Associate Director, HTA and Clinical Evaluation), Tuhin Maity (Associate ... Read More
01
May2023
PDCI Market Access is proud to announce is participation as a Platinum Sponsor of the 2023 CADTH Symposium taking place in Ottawa on May16-18, 2023.
Join PDCI’s Courtney Abunassar on May 17 at 1 p.m. during Oral Presentations 3 – Policy Issues for a ... Read More
23
Mar2023
On March 22, 2023, Federal Minister of Health Jean-Yves Duclos announced $1.5 billion in funding associated with the government’s long anticipated national rare disease strategy first announced in 2019.Most of the funding – up to $1.4 billion – which is to be allocated over the next three years, ... Read More
07
Mar2023
Eric Opoku has joined PDCI Market Access as a Health Economist and HTA Associate. In his role, he will assist with the development and review of health economics components of reimbursement submissions to HTA agencies in ... Read More
07
Mar2023
In the wake of media attention around recent high-profile resignations from PMPRB, Melanie Bourassa Forcier, former Acting Chairperson of the PMPRB who resigned in December, came forward to "rectify the facts” about her reasons for resigning this past weekend.In her 5-page letter dated March 3rd and published on ... Read More